All Work

Chris Lange

L Brands Builds Momentum With November Sales

With Christmas just around the corner and Black Friday already in the bag, holiday shopping is picking up. And this is especially true at L Brands.

Chris Lange · 9 years ago

Why Apple Is Propping Up BioTelemetry

BioTelemetry saw its shares make a handy gain on Thursday after a new partnership with Apple to provide cardiac monitoring services in conjunction with the Apple Heart Study.

Chris Lange · 9 years ago

Can Investors Stomach a New CEO at Chipotle?

Chipotle Mexican Grill shares were briefly halted on Wednesday morning after the burrito chain announced that it would begin its search for a new CEO.

Chris Lange · 9 years ago

Tuesday’s Biggest Winners and Losers in the S&P 500

Tuesday was a very strong day for U.S. broad markets in general, with each major index hitting a new all-time high. This incredible boost came from the Senate Budget Committee advancing the tax bill.…

Chris Lange · 9 years ago

Who Can Save You More, Amazon or Costco?

Amazon.com has been cleaning up on most retailers over the past few years, dominating the space through its e-commerce platform. But are its prices really that much lower?

Chris Lange · 9 years ago

Venator Materials Launches Secondary Offering

Venator Materials shares remained relatively flat after the firm announced that it would be launching a secondary offering. The company is offering 18.0 million shares with an overallotment option for an additional 4.0 million.

Chris Lange · 9 years ago

Apollo Endosurgery Surges on FDA Approval

Shares of Apollo Endosurgery saw a healthy gain early on Tuesday after the company announced it had received 510k clearance from the FDA for its OverStitch Sx.

Chris Lange · 9 years ago

Monday’s Biggest Winners and Losers in the S&P 500

Monday was mixed day for the major U.S. exchanges, although each major index hit a new all-time high at some point during the session. Crude oil backed off to start the week. The S&P…

Chris Lange · 9 years ago

Odonate Therapeutics Gears Up for IPO

Odonate Therapeutics expects to price more than 5 million shares in a range that results in an initial public offering valued up to more than $182 million.

Chris Lange · 9 years ago